Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple Sclerosis”
Stress Management for Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00147446. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
ClinicalTrials.gov study NCT00340834. IPD Sharing: Not stated. Countries: 18. Publications: 7.
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT03135249. IPD Sharing: UNDECIDED. Countries: 1. Publications: 28.
Effects of Dalfampridine on Cognition in Multiple Sclerosis
ClinicalTrials.gov study NCT02006160. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT01707992. IPD Sharing: Not stated. Countries: 30. Publications: 1.
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT03355365. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Adherence in Pediatric Multiple Sclerosis
ClinicalTrials.gov study NCT02234713. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT04261790. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®
ClinicalTrials.gov study NCT02499900. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
ClinicalTrials.gov study NCT04466150. IPD Sharing: YES. Countries: 1. Publications: 45.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01185821. IPD Sharing: Not stated. Countries: 12. Publications: 1.
The Utilization of Yoga as a Therapeutic Tool to Promote Physical Activity Behavior Change and Improved Postural Control in Individuals With Multiple Sclerosis
ClinicalTrials.gov study NCT04113135. IPD Sharing: YES. Countries: 1. Publications: 34.
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
ClinicalTrials.gov study NCT00548405. IPD Sharing: Not stated. Countries: 23. Publications: 17.
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
ClinicalTrials.gov study NCT02907177. IPD Sharing: Not stated. Countries: 20. Publications: 1.
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
ClinicalTrials.gov study NCT00841321. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01462318. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )
ClinicalTrials.gov study NCT03277261. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00678795. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT02294058. IPD Sharing: Not stated. Countries: 25. Publications: 3.
Comparison of Robot-Assisted Gait Training and Conventional Therapy in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT03801473. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.